CNTX Context Therapeutics Inc
Company Analysis
Latest News
🔴 Context Therapeutics is trading 5% down
Context Therapeutics is trading 5.09% lower at $0.22, with the reason for the decline unconfirmed. - The company’s investor-relations page lists September 9,...
🔴 Context Therapeutics is trading 10.9% down in pre-market with no confirmed catalyst
Context Therapeutics is trading 10.87% lower at $0.21 in pre-market, with the decline’s cause unconfirmed. - Its investor-relations press-release page lists...
🔴 Context Therapeutics is trading 9.3% down in pre-market as cause remains unconfirmed
Context Therapeutics is trading 9.3% down at $0.21 in pre-market, with the cause unconfirmed. - The supplied price context compares the current price with the...
🔴 Context Therapeutics is trading 5% down on October 22, 2026 amid sharp broader-market declines
Context Therapeutics is trading at $0.22 (-5.19%) in live trading on October 22, 2026, with broad-market weakness the clearest available context, not a...
🟢 Context Therapeutics is trading 5.8% up in after-hours trading with no clear company-specific catalyst identified
Context Therapeutics is trading at $0.24, up 5.79% after hours, with no clear company-specific catalyst identified. - The latest listed company release was...
🔴 Context Therapeutics is trading 5% down on October 21, 2026 as no clear catalyst emerged
Context Therapeutics is trading 5% down at $0.23 on October 21, 2026; the reason for the decline remains unclear. - No fresh company-specific announcement or...
🔴 Context Therapeutics is trading 8.53% down in pre-market
Context Therapeutics is trading at $0.22, a -8.53% change in pre-market on October 21, 2026, with no fresh company-specific announcement or overnight catalyst...
🟢 Context Therapeutics is trading 12.22% up; catalyst remains uncertain
Context Therapeutics is trading at $0.27, up 12.22%, with the catalyst uncertain. - No verified company-specific announcement explaining the October 16 move...
🔴 Context Therapeutics is trading 6% down
Context Therapeutics is trading 5.99% down at $0.23; the reason for today’s move remains uncertain. - No new company announcement or other verified...
🟢 Context Therapeutics is trading 7.23% up in pre-market
Context Therapeutics is trading 7.23% up at $0.26 in pre-market on October 16, 2026, with no verified catalyst established. - Shares closed at $0.24 on...
🟢 Context Therapeutics is trading 12.27% up in after-hours trading with no verified catalyst
Context Therapeutics is trading 12.27% higher at $0.27 after-hours, but available coverage has not established a specific reason for the rise. - It closed at...
Context Therapeutics Lands on Zacks Strong Sell List — Can a Sub-Dollar Biotech Survive Another Earnings Downgrade?
Shares of Context Therapeutics (CNTX) slid 7.75% to $0.24 on October 15 after Zacks Investment Research added the stock to its Strong Sell list, citing a 15%...
🔴 Context Therapeutics is trading 7.75% down today following Zacks' Strong Sell-list addition
Context Therapeutics is trading at $0.24, down 7.75%, after Zacks added the stock to its Strong Sell list on October 15; the report does not explicitly...
🟢 Context Therapeutics is trading 6.8% up in after-hours trading
Context Therapeutics is trading at $0.27, up 6.81% in after-hours trading, with no clear company-specific news identified to explain the rise. - A report...
🔴 Context Therapeutics is trading 5% down with no clear company-specific catalyst
Context Therapeutics is trading 5.31% down at $0.26; no clear company-specific catalyst was identified for the October 14 decline. - A report published October...
🟢 Context Therapeutics is trading 5% up in after-hours trading
Context Therapeutics is trading at $0.29, up 5.20% in after-hours trading; no clear company-specific catalyst was identified for the October 13 gain. - The...
🔴 Context Therapeutics is trading 10% down with no clear company-specific catalyst identified
Context Therapeutics is trading down 10.16% at $0.27 on October 13, 2026, with no clear company-specific catalyst identified. - The latest company...
🔴 Context Therapeutics is trading 6% down with no specific catalyst identified
Context Therapeutics is trading 6.03% lower at $0.29 on October 13, 2026, with no specific company catalyst identified. - The latest listed company release...
🔴 Context Therapeutics is trading 7.63% down in pre-market
Context Therapeutics is trading at $0.28, down 7.63% in pre-market, with no clear overnight company-specific catalyst identified. - The company’s...
🔴 Context Therapeutics is trading 5% down amid biotech-sector weakness
Context Therapeutics is trading 5.02% lower at $0.30 on October 8, 2026, alongside biotech-sector weakness and broader market pressure; no company-specific...